Alzheimer's Association International Conference to be held in Vancouver

Is it estimated that the number of Canadians afflicted with Alzheimer's disease and related dementias will increase from about 480,600 in 2008 to 1,125,000 by 2038. The statistics are frightening. This is why CIHR is currently leading a vast research effort which aims to identify the mechanisms leading to the disease; delay the onset and the progression; as well as to improve the quality of life of those living with Alzheimer's and their caregivers.

July 14-19, Canada will be the host of the Alzheimer's Association International Conference in Vancouver. In light of that upcoming conference, the following CIHR experts are available to demystify the scientific basis behind Alzheimer's. You can also read CIHR's special online series on Alzheimer's disease.

Experts:
What are Canadian researchers doing in the fight against Alzheimer's disease?
Dr. Yves Joanette, Scientific Director, CIHR Institute of Aging (Montreal, Quebec)

Is there a cure to Alzheimer's in sight?
Dr. Howard Chertkow, CIHR-funded researcher (Montreal, Quebec)

What does a brain with Alzheimer's look like?
Dr. Max S. Cynader, CIHR-funded researcher (Vancouver, British-Columbia)

How early can we detect Alzheimer's?
Dr. Sylvie Belleville, CIHR-funded researcher (Montreal, Quebec) Montreal, Quebec)

5 tips on caring for a relative with dementia
Dr. Pia Kontos, CIHR-funded researcher (Toronto, Ontario)

Optimizing care for seniors: what are the best practices?
Dr. Gloria Gutman, CIHR-funded researcher (Vancouver, British-Columbia)

Existing pharmacological treatments for people with dementia
Dr. Howard Feldman, CIHR-funded researcher (Vancouver, British-Columbia)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New protein target offers promise for alleviating cognitive decline in Parkinson's disease